About Us
Vision and Strategy
Management
Board
Advisors
History and Milestones
Group Structure
Technology
Overall Concept
Technical Implementation
Applications and Benefits
Compounds
EV-077 for Proteinuric Kidney Disease
EV-077 for Cardiovascular Disease
EV-086 for Invasive Fungal Infections
EV-086 for Topical Fungal Infections
EV-075 for Influenza
EV-075 for Haemorrhagic Fevers (in particular Ebola)
Other Compounds
Partnerships
Existing Partners
Partnering Approach
Newsroom
Investors
Chart
Stock and Key Figures
Financials
Finance History
Shareholder information
Contact
Stay Informed
Join Us
Job Opportunities
Work Environment
Diversity and Culture
Links
Contact Us
Contact Details
Locations and Directions
Join Mailing List
Shareholder information
Documents regarding EGM of 26 November 2009
Invitation (English)
Invitation (German)
Press release 26 November (English)
Press release 26 November (German)
Press release 26 November (French)
Minutes (English)
Documents Evolva Holding SA
Articles 11 December 2009 (German)
Articles 11 December 2009 (English)
Listing Notice 14 December 2009 (English)
List of key shareholders 14 December 2009 (English)
Tools
Contact Information
Legal Statement
|
Login
